鲁抗医药(600789)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600789 鲁抗医药

已收盘 08-11 15:00:00

{"stockData":{"symbol":"600789","market":"SH","secType":"STK","nameCN":"鲁抗医药","latestPrice":10.29,"timestamp":1754895600000,"preClose":10.23,"halted":0,"volume":26463460,"delay":0,"changeRate":0.0059,"floatShares":899000000,"shares":899000000,"eps":0.4517,"marketStatus":"已收盘","change":0.06,"latestTime":"08-11 15:00:00","open":10.2,"high":10.3,"low":10.18,"amount":271000000,"amplitude":0.0117,"askPrice":10.3,"askSize":5285,"bidPrice":10.29,"bidSize":2226,"shortable":0,"etf":0,"ttmEps":0.4517,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754962200000},"marketStatusCode":5,"adr":0,"adjPreClose":10.23,"symbolType":"stock","openAndCloseTimeList":[[1754875800000,1754883000000],[1754888400000,1754895600000]],"highLimit":11.25,"lowLimit":9.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":898669632,"isCdr":false,"pbRate":2.31,"roa":"--","peRate":22.780607,"roe":"2.11%","epsLYR":0.44,"committee":0.160483,"marketValue":9247000000,"turnoverRate":0.0294,"status":0,"floatMarketCap":9247000000},"requestUrl":"/m/hq/s/600789","defaultTab":"news","newsList":[{"id":"2557157839","title":"新泰市特顺汽车销售服务有限公司中标山东鲁抗医药货车更新项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2557157839","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557157839?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:14","pubTimestamp":1754662443,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年08月07日，山东鲁抗医药股份有限公司发布赛特公司物供部仓库货车更新谈判采购中标结果公告。根据公告内容，新泰市特顺汽车销售服务有限公司以成交金额86800.0元中标该项目。公示期为2025年08月07日至2025年08月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221453973bf368&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808221453973bf368&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0168","BK0046","BK0188","BK0239","600789"],"gpt_icon":0},{"id":"2557606885","title":"鲁抗医药股价小幅回落 子公司产品涉及灭蚊领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2557606885","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557606885?lang=zh_cn&edition=full","pubTime":"2025-08-08 00:16","pubTimestamp":1754583390,"startTime":"0","endTime":"0","summary":"截至2025年8月7日收盘，鲁抗医药股价报10.21元，较前一交易日下跌1.16%。当日成交额4.16亿元，换手率4.53%，总市值91.75亿元。鲁抗医药属于化学制药行业，主要业务涵盖医药制造、生物农药等领域。公司全资子公司山东鲁抗生物农药有限责任公司生产苏云金杆菌（以色列亚种），可用于灭杀蚊子幼虫。消息面上，公司在投资者互动平台表示，其子公司具备生产灭蚊相关产品的能力。资金流向方面，8月7日主力资金净流出5364.03万元，近五日累计净流出2.17亿元。风险提示：市场有风险，投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080800265194d5e47e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080800265194d5e47e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600789","BK0168","BK0239","BK0046"],"gpt_icon":0},{"id":"2557556125","title":"鲁抗医药：吉非替尼为EGFR-TKI类肺癌靶向药","url":"https://stock-news.laohu8.com/highlight/detail?id=2557556125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557556125?lang=zh_cn&edition=full","pubTime":"2025-08-07 18:00","pubTimestamp":1754560852,"startTime":"0","endTime":"0","summary":"公司仿制药吉非替尼是一种表皮生长因子受体酪氨酸激酶抑制剂，属于第一代靶向药物，是一种针对非小细胞肺癌EGFR基因突变的靶向药物，通过抑制EGFR-TK的活性来阻碍肿瘤的生长、转移和血管生成，增加肿瘤细胞的凋亡。吉非替尼在EGFR突变阳性的非小细胞肺癌患者的治疗中具有重要的地位和作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700031478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600789","BK0046","BK0168"],"gpt_icon":0},{"id":"2557355613","title":"鲁抗医药：公司旗下糖尿病药物有酒石酸罗格列酮片、阿卡波糖、格列齐特片、格列吡嗪片、达格列净片、降糖通脉胶囊","url":"https://stock-news.laohu8.com/highlight/detail?id=2557355613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557355613?lang=zh_cn&edition=full","pubTime":"2025-08-07 17:54","pubTimestamp":1754560459,"startTime":"0","endTime":"0","summary":"证券之星消息，鲁抗医药(600789)08月07日在投资者关系平台上答复投资者关心的问题。投资者提问：公司旗下糖尿病药物都有哪些？这些治疗糖尿病的药物，是否对减重有一定的效果？鲁抗医药回复：尊敬的投资者，您好！公司旗下糖尿病药物有酒石酸罗格列酮片、阿卡波糖、格列齐特片、格列吡嗪片、达格列净片、降糖通脉胶囊。不同降糖药物作用机制不同，是否对减重有效果要具体看降糖机制。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700031393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","600789","BK0239","BK0046","BK0188"],"gpt_icon":0},{"id":"2557556325","title":"鲁抗医药：苏云金杆菌可有效灭杀蚊幼虫","url":"https://stock-news.laohu8.com/highlight/detail?id=2557556325","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557556325?lang=zh_cn&edition=full","pubTime":"2025-08-07 17:42","pubTimestamp":1754559740,"startTime":"0","endTime":"0","summary":"证券之星消息，鲁抗医药(600789)08月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司的苏云金杆菌是可以用于消灭伊蚊幼虫吗？鲁抗医药回复：尊敬的投资者，您好！苏云金杆菌以色列亚种的伴孢晶体经过蚊幼虫中肠碱性环境的降解和肠道蛋白酶的酶解作用释放出毒性肽，致使幼虫麻痹，破坏蚊虫幼虫体内的钾离子（K+）平衡而中毒死亡。能有效对传播登革热、疟疾等疾病的媒介(如白纹伊蚊、按蚊、库蚊)幼虫孑孓的灭杀，从而减少蚊子成虫的产生。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700029044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","600789","BK0168","BK0239"],"gpt_icon":0},{"id":"2557534987","title":"定增“补血”与业绩“失血”：鲁抗医药的增长焦虑","url":"https://stock-news.laohu8.com/highlight/detail?id=2557534987","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557534987?lang=zh_cn&edition=full","pubTime":"2025-08-07 15:06","pubTimestamp":1754550395,"startTime":"0","endTime":"0","summary":"2025年上半年， 鲁抗医药 交出了一份难称满意的业绩“中考”。然而，在营收与净利同步承压的当下，这场募资计划是否能精准“输血”成为市场高度关注的焦点。资本市场对鲁抗医药的耐心并未完全丧失。一方面，公司具备一定的原料药与制剂产业基础，在环保趋严、供应链本地化背景下仍有短期防御性价值；另一方面，作为山东医药产业链的重要一环，鲁抗仍被寄望于成为区域医药创新生态的支撑节点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807150920a47a4ede&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807150920a47a4ede&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0046","BK0168","600789","BK0239"],"gpt_icon":0},{"id":"2557309822","title":"安徽南方化工泵业等三公司中标鲁抗医药技改项目输送泵采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2557309822","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557309822?lang=zh_cn&edition=full","pubTime":"2025-08-07 00:45","pubTimestamp":1754498703,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年08月05日，山东鲁抗医药股份有限公司发布CK25产品提取技改项目、W605产品提取技改项目输送泵采购竞争性磋商中标结果公告。公告显示，一标段中标单位为安徽南方化工泵业有限公司，中标金额为23.8万元；二标段中标单位为淄博沃杰机械科技有限公司，中标金额为15.76万元；三、四标段中标单位均为安徽奥利威泵阀机械有限公司，中标金额分别为8.8万元和15.4万元。本次公告类型为中标结果。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070046169737d14b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070046169737d14b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0188","BK0046","600789","BK0168"],"gpt_icon":0},{"id":"2557309875","title":"江苏赛德力制药机械制造有限公司中标山东鲁抗医药股份有限公司离心机采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2557309875","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557309875?lang=zh_cn&edition=full","pubTime":"2025-08-07 00:43","pubTimestamp":1754498582,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年08月05日，山东鲁抗医药股份有限公司发布了CK25产品提取技改项目离心机采购竞争性磋商的中标结果。公告显示，中标供应商为江苏赛德力制药机械制造有限公司，中标金额为36.5万元。该项目位于山东省，公告类型为中标结果。公示期为2025年08月05日至2025年08月08日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070043399737d073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070043399737d073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600789","BK0046","BK0239","BK0188","BK0168"],"gpt_icon":0},{"id":"2557783308","title":"北京新领先医药科技发展有限公司中标山东鲁抗医药仿制药药学委托研发项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2557783308","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557783308?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:05","pubTimestamp":1754489102,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年08月05日，山东鲁抗医药股份有限公司发布某仿制药药学委托研发招标竞争性磋商成交公示。公告显示，中标供应商为北京新领先医药科技发展有限公司，中标金额为125万元。此次招标公告类型为中标结果，项目位于山东省。公示期为2025年08月05日至2025年08月08日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622052697379625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622052697379625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0168","600789","159938","BK0046","BK0188","BK0239"],"gpt_icon":0},{"id":"2557344588","title":"阿尔茨海默概念盘中跳水，鲁抗医药跌1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557344588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557344588?lang=zh_cn&edition=full","pubTime":"2025-08-06 11:20","pubTimestamp":1754450447,"startTime":"0","endTime":"0","summary":"08月06日，阿尔茨海默概念盘中跳水，截至11点20分，阿尔茨海默概念整体指数下跌1.03%，报1878.970点。从个股上来看，该概念的成分股中，鲁抗医药跌1.53%，新华制药、恩华药业、赤天化跌幅居前。从资金上来看，截止发稿，阿尔茨海默概念概念主力净流入为-2.88亿，其中东诚药业受到资金热捧，主力净流入3308.20万；拉长时间线来看，该板块近20日主力资金净流入-14.53亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806112047a477c63e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806112047a477c63e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","600789","BK0239","BK0188","BK0168"],"gpt_icon":0},{"id":"2557356420","title":"阿尔茨海默概念盘中跳水，博济医药跌1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557356420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557356420?lang=zh_cn&edition=full","pubTime":"2025-08-05 10:40","pubTimestamp":1754361622,"startTime":"0","endTime":"0","summary":"08月05日，阿尔茨海默概念盘中跳水，截至10点40分，阿尔茨海默概念整体指数下跌1.04%，报1879.200点。从个股上来看，该概念的成分股中，博济医药跌1.08%，广誉远、东诚药业、鲁抗医药跌幅居前。从资金上来看，截止发稿，阿尔茨海默概念概念主力净流入为-2.18亿，其中康弘药业受到资金热捧，主力净流入621.15万；拉长时间线来看，该板块近20日主力资金净流入-14.36亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805104022a6d38060&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805104022a6d38060&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","300404","600789","BK0188","600771","BK0077","BK0239"],"gpt_icon":0},{"id":"2556825796","title":"山东兖州建设总公司中标鲁抗医药钢结构工程项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2556825796","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556825796?lang=zh_cn&edition=full","pubTime":"2025-08-02 22:55","pubTimestamp":1754146503,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年08月01日，山东鲁抗医药股份有限公司发布鲁抗医药反式乌头酸酯酯化车间钢结构工程项目公开招标中标结果公告。该项目中标金额为426.039596万元，中标供应商为山东兖州建设总公司。公示期为2025年08月01日至2025年08月04日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080222555594cb3151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080222555594cb3151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0168","BK0188","600789","BK0239"],"gpt_icon":0},{"id":"2556161813","title":"鲁抗医药：关于向特定对象发行股票申请文件审核问询函的回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2556161813","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556161813?lang=zh_cn&edition=full","pubTime":"2025-08-01 19:55","pubTimestamp":1754049324,"startTime":"0","endTime":"0","summary":"鲁抗医药公告，针对上海证券交易所关于其向特定对象发行股票申请文件的审核问询函进行了详细回复。回复内容涉及募投项目、融资规模与效益测算、经营情况等多个方面，公司及相关中介机构对问询函所列问题逐项落实并核查，明确募投项目与现有业务的关系及可行性，并披露了新药研发项目的必要性及实施可行性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801195900a6cdc2af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801195900a6cdc2af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600789","BK0168","BK0046","BK0239","BK0188"],"gpt_icon":0},{"id":"2555088564","title":"鲁抗医药(600789.SH)子公司获得盐酸伐地那非片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2555088564","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555088564?lang=zh_cn&edition=full","pubTime":"2025-07-31 17:58","pubTimestamp":1753955882,"startTime":"0","endTime":"0","summary":"智通财经APP讯，鲁抗医药 发布公告，近日，公司控股子公司山东鲁抗医药集团赛特有限责任公司收到国家药品监督管理局颁发的关于盐酸伐地那非片的《药品注册证书》，该药品是按照新注册分类4类获批的仿制药，视为通过仿制药质量和疗效一致性评价。本品适用于治疗男性阴茎勃起功能障碍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324232.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"鲁抗医药(600789.SH)子公司获得盐酸伐地那非片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0046","BK0168","BK0188","600789"],"gpt_icon":0},{"id":"2555008143","title":"超级真菌概念盘中跳水，白云山跌0.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555008143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555008143?lang=zh_cn&edition=full","pubTime":"2025-07-31 13:01","pubTimestamp":1753938110,"startTime":"0","endTime":"0","summary":"07月31日，超级真菌概念盘中跳水，截至13点01分，超级真菌概念整体指数下跌0.65%，报878.280点。从个股上来看，该概念的成分股中，白云山跌0.04%，鲁抗医药、上海凯宝、华神科技跌幅居前。从资金上来看，截止发稿，超级真菌概念主力净流入为-2.93亿，其中华海药业受到资金热捧，主力净流入6112.93万；拉长时间线来看，该板块近20日主力资金净流入-17.35亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113015097294786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073113015097294786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0012","BK0046","600521","BK0168","600789","BK0028","BK0096","600332","BK0070","BK0097","BK0183","BK0175","00874","BK0239","BK0188"],"gpt_icon":0},{"id":"2555074359","title":"阿尔茨海默概念盘中跳水，富士莱跌0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555074359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555074359?lang=zh_cn&edition=full","pubTime":"2025-07-31 10:27","pubTimestamp":1753928845,"startTime":"0","endTime":"0","summary":"07月31日，阿尔茨海默概念盘中跳水，截至10点27分，阿尔茨海默概念整体指数下跌0.57%，报1875.610点。从个股上来看，该概念的成分股中，富士莱跌0.36%，鲁抗医药、新华制药跌幅居前。从资金上来看，截止发稿，阿尔茨海默概念概念主力净流入为-1317.94万，其中*ST双成受到资金热捧，主力净流入3693.52万；拉长时间线来看，该板块近20日主力资金净流入-11.78亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073110272594c51780&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073110272594c51780&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600789","301258","BK0168","BK0239","BK0046"],"gpt_icon":0},{"id":"2555016768","title":"【聚焦】鲁抗医药出手了，抢5亿明星药国内首仿","url":"https://stock-news.laohu8.com/highlight/detail?id=2555016768","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555016768?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:03","pubTimestamp":1753862607,"startTime":"0","endTime":"0","summary":"精彩内容7月28日，山东鲁抗医药提交了非奈利酮片的4类仿制上市申请获得CDE承办。非奈利酮片是拜耳的高血压用药明星产品，2022年进入中国市场，鲁抗医药将参与该产品的国内首仿争夺。值得注意的是，非奈利酮片也是鲁抗医药首个申报上市的利尿剂，将为公司开拓新市场。非奈利酮片的亮眼成绩吸引到了众多国内药企入局，2024年9月明瑞制药首家申报该产品仿制上市，截至目前已有16家参与首仿争夺，竞争激烈。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730163310a46b33ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730163310a46b33ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0168","600789","BK0239","BK0046"],"gpt_icon":0},{"id":"2555709349","title":"阿尔茨海默概念盘中跳水，鲁抗医药跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555709349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555709349?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:55","pubTimestamp":1753840522,"startTime":"0","endTime":"0","summary":"07月30日，阿尔茨海默概念盘中跳水，截至09点55分，阿尔茨海默概念整体指数下跌0.52%，报1875.440点。从个股上来看，该概念的成分股中，鲁抗医药跌0.65%，博济医药、新华制药、康弘药业跌幅居前。从资金上来看，截止发稿，阿尔茨海默概念概念主力净流入为-1.46亿，其中东诚药业受到资金热捧，主力净流入4748.33万；拉长时间线来看，该板块近20日主力资金净流入-11.89亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095522a46a8ef0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730095522a46a8ef0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0188","BK0168","600789","BK0239"],"gpt_icon":0},{"id":"2555352200","title":"【聚焦】重庆药友制药拿下20亿注射剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2555352200","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555352200?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:13","pubTimestamp":1753776809,"startTime":"0","endTime":"0","summary":"精彩内容近日，国家药监局官网显示，重庆药友制药申报的4类仿制药注射用盐酸万古霉素获批生产并视同过评。米内网数据显示，注射用盐酸万古霉素已被纳入国家医保乙类目录，2022年以来在中国三大终端六大市场的销售额均达20亿元以上。今年以来重庆药友制药获批上市的品种来源：米内网中国申报进度数据库","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729163231a6c7768c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729163231a6c7768c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600216","600789","600812","600267","BK0060","BK0239","BK0028"],"gpt_icon":0},{"id":"2554596847","title":"阿尔茨海默概念盘中跳水，广誉远跌1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554596847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554596847?lang=zh_cn&edition=full","pubTime":"2025-07-25 14:24","pubTimestamp":1753424672,"startTime":"0","endTime":"0","summary":"07月25日，阿尔茨海默概念盘中跳水，截至14点24分，阿尔茨海默概念整体指数下跌1.02%，报1809.250点。从个股上来看，该概念的成分股中，广誉远跌1.04%，富士莱、双鹭药业、鲁抗医药跌幅居前。从资金上来看，截止发稿，阿尔茨海默概念概念主力净流入为-1.87亿，其中睿智医药受到资金热捧，主力净流入4057.51万；拉长时间线来看，该板块近20日主力资金净流入-16.59亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725142432a6c109c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725142432a6c109c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0046","600771","BK0188","BK0077","600789","BK0168"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754903077438,"stockEarnings":[{"period":"1week","weight":-0.0285},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0213},{"period":"6month","weight":0.0356},{"period":"1year","weight":0.285},{"period":"ytd","weight":0.0833}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.0877},{"period":"6month","weight":0.1003},{"period":"1year","weight":0.2666},{"period":"ytd","weight":0.0845}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东鲁抗医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"127650人(较上一季度减少3.80%)","perCapita":"7040股","listingDate":"1997-02-26","address":"山东省济宁市兖州区高新区德源路88号","registeredCapital":"89866万元","survey":"　　山东鲁抗医药股份有限公司的主营业务是医药产品的研发、生产和销售等业务。公司的主要产品是原料药、制剂药品、兽用药、其他。2024年，公司在工信部发布的中国医药工业百强榜列第48位。公司被评为山东省质量标杆企业、山东省药品上市许可持有人药物警戒规范化实践基地，2023-2024年度两化融合管理体系升级版贯标A级优秀企业、2024年省级智能工厂。","listedPrice":6.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鲁抗医药(600789)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鲁抗医药(600789)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鲁抗医药,600789,鲁抗医药股票,鲁抗医药股票老虎,鲁抗医药股票老虎国际,鲁抗医药行情,鲁抗医药股票行情,鲁抗医药股价,鲁抗医药股市,鲁抗医药股票价格,鲁抗医药股票交易,鲁抗医药股票购买,鲁抗医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鲁抗医药(600789)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鲁抗医药(600789)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}